LetterCorrespondence
Both Etanercept and Infliximab Can Elevate Tumor Necrosis Factor (TNF)-α and Be the Cause of Treatment Related New Onset Disease: the Need to Measure Circulating TNF-α
RICHARD E. KAST and ERIC L. ALTSCHULER
The Journal of Rheumatology August 2008, 35 (8) 1679;
In this issue
Both Etanercept and Infliximab Can Elevate Tumor Necrosis Factor (TNF)-α and Be the Cause of Treatment Related New Onset Disease: the Need to Measure Circulating TNF-α
RICHARD E. KAST, ERIC L. ALTSCHULER
The Journal of Rheumatology Aug 2008, 35 (8) 1679;